致死性中毒由于aconite:解剖结果和死后定量分析
Huang Weisheng1,2, Zhao Shuquan3, Zhu Weiwei1
1Department of Forensic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
这项研究发现,在治疗阿科尼丁中毒12天后,肝脏组织中发现了阿科尼丁. 这表明,在长时间暴露于阿科尼的情况下,肝脏组织可能对法医毒理学有价值.
科学领域:
- 法医毒理学 法医毒理学
- 传统中国医药 传统中国医药
- 药理学 药理学是指药理学的学科.
背景情况:
- 在传统中医药中使用阿科尼物种,但由于治疗窗口狭窄,可能会造成阿科尼中毒的风险.
- 在法医实践中,阿科尼中毒死亡很少见,快速吸收/分泌需要及时采集样本.
- 在长期治疗后,在死后样本中阿科尼丁的持久性仍然不清楚.
研究的目的:
- 调查死后样本的价值,以便在长时间暴露于阿科尼丁的情况下进行毒理学分析.
- 在患者接受了12天的毒素活性治疗后,报告在肝组织中检测到阿科尼丁.
主要方法:
- 一个致命的阿科尼中毒案例报告.
- 对死后样本的毒理学分析,特别是肝脏组织.
主要成果:
- 在死者的肝脏组织中成功检测到阿科尼丁.
- 这种检测发生在开始对阿科尼中毒的活性治疗12天后.
结论:
- 肝脏组织可以保持可检测的尼丁度,即使在长期治疗尼丁中毒后.
- 这一发现为类似案件的法医毒理学分析提供了有价值的参考信息.
更多相关视频
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
09:16Author Spotlight: Optimization of Processing Technology for Tiebangchui with Zanba Based on CRITIC Combined with Box-Behnken Response Surface Method
Published on: May 12, 2023
相关概念视频
Physical Properties of Amines
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Prevention of Further Absorption of Poison
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
